微譜聚焦生物醫(yī)藥領域，致力于成為您值得信賴的醫(yī)藥研發(fā)伙伴。我們密切關注全球生物醫(yī)藥行業(yè)發(fā)展趨勢，整合出藥品包材理、化學藥品質量研究、生物制品研究、醫(yī)療器械檢測服務等多平臺服務，以完備的質量體系、高速的交付周期、豐富的項目經驗及持續(xù)擴張的能力布局，2024年5月，微譜藥物及醫(yī)療器械實驗室成功通過美國FDA現場核查。我們的報告得到了中國、歐盟、美國、WHO等國際主要市場監(jiān)管機構的認可，成功助力3500余家藥物及醫(yī)療器械企業(yè)加速產品上市進程！ 

Weipu focuses on the field of biomedicine and is committed to becoming your trusted pharmaceutical research and development partner. We closely monitor the development trends of the global biopharmaceutical industry, integrating multiple platform services such as drug packaging material management, chemical drug quality research, biological product research, and medical device testing services. With a complete quality system, high-speed delivery cycle, rich project experience, and continuous expansion capability layout, in May 2024, Weipu Drug and Medical Device Laboratory successfully passed the on-site inspection of the US FDA. Our report has been recognized by major international market regulatory agencies such as China, the European Union, the United States, and WHO, successfully assisting over 3500 pharmaceutical and medical device companies in accelerating their product launch processes!